Related Experiment Video

Updated: Aug 19, 2026

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians
06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

[Adamantiades-Behcet's disease]

L Krause1

  • 1Augenklinik, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin. lothar.krause@charite.de

Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft
|January 26, 2005
PubMed

Insights

Adamantiades-Behcet's disease (ABD) is a chronic vasculitis with unclear origins, affecting multiple organs. Ocular involvement is common and can lead to blindness, necessitating further research into advanced treatments.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Immunology

Context:

  • Adamantiades-Behcet's disease (ABD) is a multisystemic vasculitis of unknown etiology.
  • It predominantly affects populations in Mediterranean, Middle Eastern, and Far Eastern countries but is increasingly recognized globally.
  • Clinical manifestations include recurrent oral/genital ulcers, arthritis, skin lesions, and significant ocular involvement.

Purpose:

  • To summarize the key clinical features and current understanding of Adamantiades-Behcet's disease.
  • To highlight the prevalence and severity of ocular manifestations in ABD.
  • To briefly mention existing and emerging treatment strategies for ocular involvement.

Summary:

  • Adamantiades-Behcet's disease (ABD) is characterized by recurrent ulcers, arthritis, and skin issues.
  • Ocular involvement, including retinal vasculitis and panuveitis, occurs in 60-80% of patients, potentially causing blindness in 20-50% of cases.
  • Current treatments involve steroids, cyclosporin A, and azathioprine, with ongoing studies on interferon-alpha and TNF antibodies.

Impact:

  • Increased global awareness of Adamantiades-Behcet's disease due to human mobility.
  • Highlights the critical need for effective management of ocular complications to prevent vision loss.
  • Underscores the importance of continued research into novel therapeutic targets for ABD.

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...